Episode Details

Back to Episodes
Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

Published 6 months, 3 weeks ago
Description
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us